Reference Material Information Sheets and Analysis Instructions

General information

The following forms are for active Newborn Screening Quality Assurance Program participants. If you have questions or access issues with forms or reporting, please contact the program for help.

Participation request forms

To submit a new NSQAP participation request or to modify your existing participation enrollment, please visit the NSQAP Participant Portal.

Shipping guidelines for dried blood spots

Shipping Guidelines for Dried Blood Spot Specimens

Shipping schedule

Please check back for updates.

Quality control data reporting

NSQAP Participant Portal

Quality Control Assaying and Reporting Instructions

QC Portal User Guide

17 a-Hydroxyprogesterone + Total Galactose
(17OHP): Revvity GSP Neonatal
(TGAL): Revvity Neonatal Kit
Lots: A2305, B2305, C2305

Second-tier Congenital Adrenal Hyperplasia by LC-MS/MS
LC-MS/MS
Lots: A2311, B2311, C2311, D2311, E2311

GALT/Galactose-1-phosphate Uridyltransferase
Revvity Neonatal GALT Kit
Lots: A2303, B2303, C2303

anti-HIV Antibodies
Avioq HIV-1 Microelisa
Lots: A2307, B2307, C2307, D2307

Cystic Fibrosis (CFTR) DNA
xTAG® Cystic Fibrosis (CFTR) 60 kit v2
Lots: A2204-U2204

Immunoreactive Trypsinogen
Revvity GSP Neonatal
Lots: A2309, B2309, C2309, D2309

Lysosomal Storage Disorders
Lots: A2308, B2308, C2308, D2308

Second-tier Methylmalonic/Propionic Acidemia and Homocystinuria by LC-MS/MS
LC-MS/MS
Lots: A2314, B2314, C2314, D2314

Tandem MS 1
Derivatized – MS/MS non-kit
Lots: A2415, B2415, C2415, D2415

Tandem MS 1
Non-derivatized – MS/MS non-kit
Lots: A2415, B2415, C2415, D2415

Second-tier Maple Syrup Urine Disease and Phenylketonuria by LC-MS/MS
LC-MS/MS
Lots: A2313, B2313, C2313, D2313, E2313

Thyroxine
Revvity GSP Neonatal
Lots: A2300, B2300, C2300

Thyroid-Stimulating Hormone
Revvity GSP Neonatal
Lots: A2401, B2401, C2401

Proficiency testing data reporting

Anti-HIV-1 Antibodies in Dried Blood Spots (HIVPT)

Proficiency Testing Assay Instructions anti-Toxoplasma Antibodies (TOXOPT)

Second-tier Congenital Adrenal Hyperplasia by LC-MS/MS (CAHPT)

Cystic Fibrosis Mutation Detection (CFDNAPT)

Adrenoleukodystrophy (ALDPT)

Lysosomal Storage Disorders (LSDPT)

Sickle Cell Disease and Other Hemoglobinopathies (HbPT)

Spinal Muscular Atrophy (SMA)

T-cell Receptor Excision Circle (TRECPT)